Fundraising Fox

Checkmate Pharmaceuticals

Cambridge, US · Founded 2015 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

BL
Barry LabingerExecutive Officer, Director
BA
Ben AuspitzDirector
AK
Art KriegExecutive Officer, Director
CA
Chuck AbdalianExecutive Officer
DM
David MauroExecutive Officer
KB
Karen BrennanExecutive Officer
CY
Charles YonExecutive Officer
MP
Michael PowellDirector
CG
Corey GoodmanDirector

Investors · 1

F-Prime Capital PartnersCambridge · $3M – $10Mvia Robert Weisskoff · board

Reported raises · per SEC filings

Form D private placements
▶$85.1MraisedJun 2020 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James WooldridgeExecutive Officer
  • Karen BrennanExecutive Officer
  • Kleem ChaudharyExecutive Officer
  • Robert WeisskoffDirector
  • Jonathan LieberExecutive Officer
  • Michael PowellDirector
  • Barry LabingerExecutive Officer, Director
  • Corey GoodmanDirector
  • Peter ColabuonoDirector
  • Keith FlahertyDirector
  • Charles YonExecutive Officer
  • Alan FuhrmanDirector
  • Arthur KriegExecutive Officer, Director
Offering amount
$100.1M
Amount sold
$85.1M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles YonExecutive Officer
  • James WooldridgeExecutive Officer
  • Jonathan LieberExecutive Officer
  • Arthur KriegExecutive Officer, Director
  • Barry LabingerExecutive Officer, Director
  • Keith FlahertyDirector
  • Michael PowellDirector
  • Corey GoodmanDirector
  • Kleem ChaudharyExecutive Officer
  • Alan FuhrmanDirector
  • Karen BrennanExecutive Officer
  • Peter ColabuonoDirector
  • Robert WeisskoffDirector
Offering amount
$10M
Amount sold
$10M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedJan 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry LabingerExecutive Officer, Director
  • Arthur KriegExecutive Officer, Director
  • Robert WeisskoffDirector
  • Jonathan LieberExecutive Officer
  • Karen BrennanExecutive Officer
  • James WooldridgeExecutive Officer
  • Kleem ChaudharyExecutive Officer
  • Charles YonExecutive Officer
  • Michael PowellDirector
  • Corey GoodmanDirector
  • Keith FlahertyDirector
  • Alan FuhrmanDirector
  • Peter ColabuonoDirector
Offering amount
$16M
Amount sold
$16M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22MraisedApr 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry LabingerExecutive Officer, Director
  • Ben AuspitzDirector
  • Art KriegExecutive Officer, Director
  • Chuck AbdalianExecutive Officer
  • David MauroExecutive Officer
  • Karen BrennanExecutive Officer
  • Charles YonExecutive Officer
  • Michael PowellDirector
  • Corey GoodmanDirector
Offering amount
$22M
Amount sold
$22M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27MraisedJun 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Corey GoodmanDirector
  • David MauroExecutive Officer
  • Ben AuspitzDirector
  • Michael PowellDirector
  • Charles YonExecutive Officer
  • Charles AbdalianExecutive Officer
  • Arthur M. KriegExecutive Officer, Director
  • Ramani VaranasiExecutive Officer
Offering amount
$27M
Amount sold
$27M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedFeb 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Corey GoodmanDirector
  • Arthur A. KriegExecutive Officer, Director
  • Michael PowellDirector
  • Chuck AbdalianExecutive Officer
Offering amount
$25M
Amount sold
$25M
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.